Krystal Biotech (KRYS) Inventory (2023 - 2026)
Krystal Biotech (KRYS) posted quarterly Inventory of $45.6 million for Q2 2026, up 46.76% year-over-year from $31.0 million in Q2 2025, and up 6.82% on a QoQ basis from $42.6 million in Q1 2026.
Krystal Biotech (KRYS) Inventory (2023 - 2026) Analysis & Trends
Krystal Biotech has reported Inventory for 4 years, with the latest figure at $45.6 million in Q2 2026.
- Inventory for Q2 2026 came in at $45.6 million, up 46.76% year-over-year; the trailing twelve-month figure through Jun 2026 was $45.6 million (up 46.76% YoY), and the FY2025 annual result was $40.5 million, up 52.69% from the prior year.
- Inventory improved to $45.6 million in Q2 2026, from $42.6 million in the prior quarter.
- Over five years, Inventory peaked at $45.6 million in Q2 2026 and troughed at $5.3 million in Q3 2023.
- A 4-year average of $25.7 million and a median of $28.2 million in 2024 frame the typical range for Inventory.
- The widest annual swing landed in 2024, when Inventory surged 279.5%; it then surged 42.43% in 2026.
- A 4-year view of Inventory shows it stood at $7.0 million in 2023, then surged by 279.5% to $26.5 million in 2024, then jumped by 52.69% to $40.5 million in 2025, then rose by 12.55% to $45.6 million in 2026.
- Per Business Quant data, the three most recent Inventory figures were $45.6 million in Q2 2026, $42.6 million in Q1 2026, and $40.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Krystal Biotech | 9.83 Bn | 8.99 Bn | 112.79 Mn | 45.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.56 Mn |
| Mar 31, 2026 | 42.65 Mn |
| Dec 31, 2025 | 40.48 Mn |
| Sep 30, 2025 | 37.63 Mn |
| Jun 30, 2025 | 31.04 Mn |
| Mar 31, 2025 | 29.94 Mn |
| Dec 31, 2024 | 26.51 Mn |
| Sep 30, 2024 | 18.58 Mn |
| Jun 30, 2024 | 12.18 Mn |
| Mar 31, 2024 | 11.04 Mn |
| Dec 31, 2023 | 6.99 Mn |
| Sep 30, 2023 | 5.28 Mn |